References
- BrinkmannVCysterJGHlaTFTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier functionAm J Transplant2004471019102515196057
- BrinkmannVFTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous systemBr J Pharmacol200915851173118219814729
- KapposLRadueEWO’ConnorPFREEDOMS Study GroupA placebo-controlled trial of oral fingolimod in relapsing multiple sclerosisN Engl J Med2010362538740120089952
- CohenJABarkhofFComiGTRANSFORMS Study GroupOral fingolimod or intramuscular interferon for relapsing multiple sclerosisN Engl J Med2010362540241520089954
- AmmitAJHastieATEdsallLCSphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthmaFASEB J20011571212121411344091
- BoultonCMeiserKDavidOJSchmouderRPharmacodynamic effects of steady-state fingolimod on antibody response in healthy volunteers: a 4-week, randomized, placebo-controlled, parallel-group, multiple-dose studyJ Clin Pharmacol201252121879189022174429
- PelletierDHaflerDAFingolimod for multiple sclerosisN Engl J Med2012366433934722276823